These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23241075)

  • 1. Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers.
    Secreto G; Venturelli E; Meneghini E; Carcangiu ML; Paolini B; Agresti R; Pellitteri C; Berrino F; Gion M; Cogliati P; Saragò G; Micheli A
    BMC Cancer; 2012 Dec; 12():599. PubMed ID: 23241075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-Menopausal Women With Breast Cancers Having High AR/ER Ratios in the Context of Higher Circulating Testosterone Tend to Have Poorer Outcomes.
    Rajarajan S; Korlimarla A; Alexander A; Anupama CE; Ramesh R; Srinath BS; Sridhar TS; Prabhu JS
    Front Endocrinol (Lausanne); 2021; 12():679756. PubMed ID: 34234742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98.
    Kensler KH; Regan MM; Heng YJ; Baker GM; Pyle ME; Schnitt SJ; Hazra A; Kammler R; Thürlimann B; Colleoni M; Viale G; Brown M; Tamimi RM
    Breast Cancer Res; 2019 Feb; 21(1):30. PubMed ID: 30795773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers.
    Tsang JY; Ni YB; Chan SK; Shao MM; Law BK; Tan PH; Tse GM
    Ann Surg Oncol; 2014 Jul; 21(7):2218-28. PubMed ID: 24639191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor expression and breast cancer survival in postmenopausal women.
    Hu R; Dawood S; Holmes MD; Collins LC; Schnitt SJ; Cole K; Marotti JD; Hankinson SE; Colditz GA; Tamimi RM
    Clin Cancer Res; 2011 Apr; 17(7):1867-74. PubMed ID: 21325075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women.
    Fourkala EO; Zaikin A; Burnell M; Gentry-Maharaj A; Ford J; Gunu R; Soromani C; Hasenbrink G; Jacobs I; Dawnay A; Widschwendter M; Lichtenberg-Fraté H; Menon U
    Endocr Relat Cancer; 2012 Apr; 19(2):137-47. PubMed ID: 22199143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status.
    Zhang X; Eliassen AH; Tamimi RM; Hazra A; Beck AH; Brown M; Collins LC; Rosner B; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):962-8. PubMed ID: 25855627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Androgen Receptor Supports Tumor Progression After the Loss of Ovarian Function in a Preclinical Model of Obesity and Breast Cancer.
    Wellberg EA; Checkley LA; Giles ED; Johnson SJ; Oljira R; Wahdan-Alaswad R; Foright RM; Dooley G; Edgerton SM; Jindal S; Johnson GC; Richer JK; Kabos P; Thor AD; Schedin P; MacLean PS; Anderson SM
    Horm Cancer; 2017 Dec; 8(5-6):269-285. PubMed ID: 28741260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor expression in a Sri Lankan patient cohort with early breast carcinoma.
    Wijesinghe HD; Wijesinghe GK; Mansoor Z; Vigneshwara S; Fernando J; Gunasekera D; Lokuhetty MDS
    BMC Womens Health; 2020 Sep; 20(1):206. PubMed ID: 32928183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer.
    Tokunaga E; Hisamatsu Y; Taketani K; Yamashita N; Akiyoshi S; Okada S; Tanaka K; Saeki H; Oki E; Aishima S; Oda Y; Morita M; Maehara Y
    Cancer Med; 2013 Dec; 2(6):763-73. PubMed ID: 24403250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of androgen receptors in primary breast cancer.
    Park S; Koo J; Park HS; Kim JH; Choi SY; Lee JH; Park BW; Lee KS
    Ann Oncol; 2010 Mar; 21(3):488-492. PubMed ID: 19887463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer.
    García X; Elía A; Galizzi L; May M; Spengler E; Martínez Vázquez P; Burruchaga J; Gass H; Lanari C; Lamb CA
    Breast Cancer Res Treat; 2020 Feb; 180(1):257-263. PubMed ID: 31950383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
    Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers.
    Ogawa Y; Hai E; Matsumoto K; Ikeda K; Tokunaga S; Nagahara H; Sakurai K; Inoue T; Nishiguchi Y
    Int J Clin Oncol; 2008 Oct; 13(5):431-5. PubMed ID: 18946753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone and biological characteristics of breast cancers in postmenopausal women.
    Secreto G; Venturelli E; Meneghini E; Greco M; Ferraris C; Gion M; Zancan M; Fabricio AS; Berrino F; Cavalleri A; Micheli A
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2942-8. PubMed ID: 19843675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker Associations with Efficacy of Abiraterone Acetate and Exemestane in Postmenopausal Patients with Estrogen Receptor-Positive Metastatic Breast Cancer.
    Li W; O'Shaughnessy J; Hayes D; Campone M; Bondarenko I; Zbarskaya I; Brain E; Stenina M; Ivanova O; Graas MP; Neven P; Ricci D; Griffin T; Kheoh T; Yu M; Gormley M; Martin J; Schaffer M; Zelinsky K; De Porre P; Johnston SR
    Clin Cancer Res; 2016 Dec; 22(24):6002-6009. PubMed ID: 27267854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer?
    Arslan C; Isik M; Guler G; Kulac I; Solak M; Turker B; Ozisik Y; Altundag K
    Am Surg; 2012 Sep; 78(9):992-9. PubMed ID: 22964210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: a multivariate analysis approach.
    Brentani MM; Franco EL; Oshima CT; Pacheco MM
    Int J Cancer; 1986 Nov; 38(5):637-42. PubMed ID: 3770993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating sex hormones and tumor characteristics in postmenopausal breast cancer patients. A cross-sectional study.
    Secreto G; Meneghini E; Venturelli E; Cogliati P; Agresti R; Ferraris C; Gion M; Zancan M; Fabricio AS; Berrino F; Cavalleri A; Micheli A
    Int J Biol Markers; 2011; 26(4):241-6. PubMed ID: 22180173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.